Literature DB >> 8986945

Molecular subtyping of human T-lymphotropic virus type I (HTLV-I) by a nested polymerase chain reaction-restriction fragment length polymorphism analysis of the envelope gene: two distinct lineages of HTLV-I in Taiwan.

Y C Yang1, T Y Hsu, M Y Liu, M T Lin, J Y Chen, C S Yang.   

Abstract

The major type of human T-lymphotropic virus type I (HTLV-I), generally referred to as the cosmopolitan type, has been grouped into three subtypes (A, B, and C) by phylogenetic analysis of the long terminal repeat sequences of the viral genome. Twelve subtype-specific nucleotide variations have been deduced by comparison between the envelope (env) sequences of 16 HTLV-I strains with defined subtypes and 9 Taiwanese HTLV-I strains. To gain further insights into the molecular epidemiology of HTLV-I and the origin of this virus in Taiwan, a rapid method of identification for the cosmopolitan subtypes was developed by using a nested polymerase chain reaction (PCR) and subsequent restriction fragment length polymorphism (RFLP) studies using the two subtype B-specific and four subtype C-specific nucleotides located within the positions 5708 to 6320 of the envgene. The nested PCR-RFLP method was used to subtype HTLV-I from four virus-positive cell lines derived from 1 Japanese and 3 North American patients, as well as 41 blood-unrelated Taiwan Chinese. The sequences of PCR products were determined and the six positions of subtype-specific nucleotide variations were examined. The sequence data completely supported the subtyping data via the nested PCR-RFLP method. The results demonstrated that, as is the case in Japan, at least two distinct cosmopolitan subtypes (A and B) of HTLV-I were present in Taiwan, but the more prevalent subtype in Taiwan is A in contrast to subtype B in Japan. Furthermore, rapid subtyping could facilitate molecular epidemiological studies of HTLV-I infection and linkage between HTLV-I subtypes and virus-associated diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8986945

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.

Authors:  Lee R Silverman; Andrew J Phipps; Andy Montgomery; Soledad Fernandez; Tomonori Tsukahara; Lee Ratner; Michael D Lairmore
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

2.  Design of new potent HTLV-1 protease inhibitors: in silico study.

Authors:  Mitra Kheirabadi; Javad Maleki; Safieh Soufian; Samaneh Hosseini
Journal:  Mol Biol Res Commun       Date:  2016-03

3.  Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan.

Authors:  Masashi Otani; Katsuyuki Eguchi; Tatsuki Ichikawa; Kohei Takenaka Takano; Toshiki Watanabe; Kazunari Yamaguchi; Kazuhiko Nakao; Taro Yamamoto
Journal:  Trop Med Health       Date:  2013-01-19

4.  Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic Japan.

Authors:  Masashi Otani; Noritaka Honda; Pin-Cang Xia; Katsuyuki Eguchi; Tatsuki Ichikawa; Toshiki Watanabe; Kazunari Yamaguchi; Kazuhiko Nakao; Taro Yamamoto
Journal:  Trop Med Health       Date:  2012-08-04

5.  Genome-wide analyses of HTLV-1aD strains from Cape Verde, Africa.

Authors:  Louise Zanella; Isabel de Pina-Araujo I; Mariza G Morgado; Ana Carolina Vicente
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-09       Impact factor: 2.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.